Aarti Pharmalabs Limited
Aarti Pharmalabs Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: AARTIPHARM and BSE: 543748 (ISIN INE0LRU01027).
It has a market capitalisation of ₹7,546 crore, a last close of ₹832.35 on 2026-10-19, a one-year return of -0.2%.
Valuation: a price-to-earnings ratio of 35.56x, a price-to-book ratio of 3.55x, a dividend yield of 0.4%.
Profitability: return on equity of 8.4%, return on capital employed of 11.3%, an operating margin of 21.6%.
Growth: sales growth of -2.2% a year over three years, net profit growth of -3.7% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.32x, promoter holding of 39.7%.
| Metric | Value |
|---|---|
| Market capitalisation | 7,546 |
| Last close | ₹832.35 |
| P/E (TTM) | 35.56x |
| P/B | 3.55x |
| Dividend yield | 0.4% |
| ROE (FY) | 8.4% |
| ROCE (FY) | 11.3% |
| Operating margin (TTM) | 21.6% |
| Sales growth, 3-year CAGR | -2.2% |
| Profit growth, 3-year CAGR | -3.7% |
| Debt / equity | 0.32x |
| Promoter holding | 39.7% |
| 1-year return | -0.2% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means